Holen Sie sich die Stockscreener-App
3.40
1.80%
0.06
Handel nachbörslich:
3.39
-0.010
-0.29%
Schlusskurs vom Vortag:
$3.34
Offen:
$3.4
24-Stunden-Volumen:
1.26M
Relative Volume:
0.31
Marktkapitalisierung:
$457.55M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-217.44M
KGV:
-1.5668
EPS:
-2.17
Netto-Cashflow:
$-205.20M
1W Leistung:
-1.16%
1M Leistung:
-24.44%
6M Leistung:
+54.20%
1J Leistung:
-11.80%
1-Tages-Spanne:
$3.25
$3.4625
1-Wochen-Bereich:
$3.09
$3.49
52-Wochen-Spanne:
$1.11
$5.17
Prime Medicine Inc Stock (PRME) Company Profile
Firmenname
Prime Medicine Inc
Sektor
Branche
Telefon
617-465-0013
Adresse
60 FIRST ST., CAMBRIDGE
Vergleichen Sie PRME mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRME
Prime Medicine Inc
|
3.40 | 556.21M | 0 | -217.44M | -205.20M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Prime Medicine Inc Stock (PRME) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-27 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-20 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-05-20 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-12-10 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-16 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-04-22 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-04-08 | Eingeleitet | TD Cowen | Buy |
| 2024-04-03 | Eingeleitet | Wedbush | Outperform |
| 2024-01-16 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-08 | Eingeleitet | Citigroup | Neutral |
| 2023-10-09 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-07-31 | Eingeleitet | Guggenheim | Buy |
| 2023-04-18 | Eingeleitet | Stifel | Buy |
| 2022-11-14 | Eingeleitet | Goldman | Neutral |
| 2022-11-14 | Eingeleitet | JP Morgan | Overweight |
| 2022-11-14 | Eingeleitet | Jefferies | Buy |
| 2022-11-14 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Prime Medicine Inc Aktie (PRME) Neueste Nachrichten
Prime Medicine, Inc. shares rise 7.85% intraday after presenting at Citi's Biopharma Back to School event. - AInvest
Can a trend reversal in Prime Medicine Inc. lead to recovery2025 Winners & Losers & Comprehensive Market Scan Insights - Newser
Can machine learning forecast Prime Medicine Inc. recoveryMarket Movers & Consistent Growth Equity Picks - Newser
Analyzing Prime Medicine Inc. with multi timeframe chartsEarnings Beat & High Conviction Buy Zone Picks - Newser
Is this a good reentry point in Prime Medicine Inc.2025 Price Targets & Community Consensus Picks - Newser
Will Prime Medicine Inc. continue its uptrendMarket Trend Report & Consistent Income Trade Ideas - Newser
What moving averages say about Prime Medicine Inc.Portfolio Risk Report & Reliable Entry Point Trade Alerts - Newser
Is Prime Medicine Inc. stock reversal real or fakeJuly 2025 Sector Moves & Community Consensus Trade Alerts - Newser
Multi asset correlation models including Prime Medicine Inc.2025 Volatility Report & Community Shared Stock Ideas - Newser
Can volume confirm reversal in Prime Medicine Inc.July 2025 Selloffs & Intraday High Probability Setup Alerts - Newser
Evaluating Prime Medicine Inc. with trendline analysis2025 Year in Review & Risk Controlled Swing Trade Alerts - Newser
What data driven models say about Prime Medicine Inc.’s futurePortfolio Value Summary & Low Drawdown Investment Ideas - Newser
Can Prime Medicine Inc. disrupt its industryWeekly Investment Summary & Daily Momentum Trading Reports - khodrobank.com
Prime Medicine Inc. stock trendline breakdownWeekly Stock Report & Low Volatility Stock Recommendations - Newser
Why is Prime Medicine Inc. stock going upJuly 2025 Action & Free High Accuracy Swing Entry Alerts - khodrobank.com
Prime Medicine Inc. Recovery Hinges on Volume BreakoutJuly 2025 Action & High Return Trade Opportunity Guides - beatles.ru
Can Prime Medicine Inc. reach resistance levels soonJuly 2025 Intraday Action & Weekly Sector Rotation Insights - khodrobank.com
Is Prime Medicine Inc. exposed to political riskMarket Growth Summary & High Accuracy Swing Entry Alerts - khodrobank.com
How moving averages guide Prime Medicine Inc. tradingJuly 2025 Price Swings & Advanced Technical Analysis Signals - Newser
Will Prime Medicine Inc. stock go up soonJuly 2025 Recap & High Conviction Buy Zone Picks - Newser
Aug Macro: Is Prime Medicine Inc. forming a breakout patternJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - khodrobank.com
Citi Downgrades Prime Medicine (PRME) to Neutral, Cuts PT to $1.50 Due to Market Uncertainty - MSN
What’s the profit margin of Prime Medicine Inc.Portfolio Performance Summary & Daily Stock Trend Watchlist - khodrobank.com
Will Prime Medicine Inc. bounce back from current supportJuly 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
Strategies to average down on Prime Medicine Inc.Earnings Risk Report & AI Forecast Swing Trade Picks - Newser
PRME.O Drops 5.8% on Technical Weakness Amid Mixed Peer Activity - AInvest
Prime Medicine (PRME.O) Faces Sharp Intraday Drop Despite No New Fundamental News - AInvest
Advanced analytics toolkit walkthrough for Prime Medicine Inc.Breakout Watch & Risk Controlled Stock Pick Alerts - Newser
Market reaction to Prime Medicine Inc.’s recent newsPortfolio Gains Summary & Stepwise Entry/Exit Trade Alerts - Newser
Can Prime Medicine Inc. hit a new high this monthWeekly Earnings Recap & Daily Oversold Bounce Ideas - Newser
Will Prime Medicine Inc. rebound enough to break even2025 Volatility Report & Fast Entry and Exit Trade Plans - Newser
Prime Medicine Plummets Over 5% Amid Technical Downturn and Mixed Peer Activity - AInvest
Prime Medicine (PRME.O) Sharp Intraday Drop: A Technical and Peer-Driven Deep Dive - AInvest
Prime Medicine (PRME.O) Plummets 5.8% Amid Mixed Technicals and Weak Sector Cues - AInvest
Visual trend scoring systems applied to Prime Medicine Inc.Jobs Report & Verified Swing Trading Watchlist - Newser
Historical volatility pattern of Prime Medicine Inc. visualizedWeekly Gains Summary & Daily Stock Trend Watchlist - Newser
Prime Medicine Inc. Stock Poised for Technical Comeback getLinesFromResByArray error: size == 0 - thegnnews.com
Finanzdaten der Prime Medicine Inc-Aktie (PRME)
Umsatz
Nettogewinn
Free Cashflow
ENV
Prime Medicine Inc-Aktie (PRME) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| NELSEN ROBERT | Director |
Aug 01 '25 |
Buy |
3.30 |
3,030,300 |
9,999,990 |
6,230,300 |
| ARCH Venture Partners XII, LLC | 10% Owner |
Aug 01 '25 |
Buy |
3.30 |
3,030,300 |
9,999,990 |
6,230,300 |
| ARCH Venture Partners X, LLC | 10% Owner |
Aug 01 '25 |
Buy |
3.30 |
3,030,300 |
9,999,990 |
6,230,300 |
| Liu David R. | 10% Owner |
Jun 30 '25 |
Buy |
2.52 |
21,000 |
52,830 |
20,240,945 |
| Liu David R. | 10% Owner |
Jun 23 '25 |
Buy |
2.16 |
21,000 |
45,402 |
20,219,945 |
| Liu David R. | 10% Owner |
Jun 16 '25 |
Buy |
1.49 |
21,000 |
31,196 |
20,198,945 |
| Liu David R. | 10% Owner |
Jun 11 '25 |
Buy |
1.60 |
21,000 |
33,590 |
20,177,945 |
| Brudnick Richard | Chief Business Officer |
May 20 '25 |
Buy |
1.19 |
20,000 |
23,790 |
20,000 |
| LEE ANN L. | Chief Technical Officer |
May 21 '25 |
Buy |
1.13 |
100,000 |
113,000 |
100,000 |
| Reine Allan | Chief Executive Officer |
May 21 '25 |
Buy |
1.18 |
125,000 |
147,150 |
125,000 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):